Neurocognitive performance in breast cancer survivors (BCS): Exploring the relationship with adjuvant treatment, psychological and reproductive factors

S. A. Castellon(University of California, Los Angeles), Gail A. Greendale(University of California, Los Angeles), P. A. Ganz(UCLA Health), Laura Petersen(APLA Health), Julienne E. Bower(APLA Health)
Journal of Clinical Oncology
July 15, 2004
10.1200/jco.2004.22.14_suppl.8028
Cited by 1

Related Papers

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial
|JAMA|1995|605
Breast Cancer in Younger Women: Reproductive and Late Health Effects of Treatment
|Journal of Clinical Oncology|2003|530
Breast cancer survivors: Psychosocial concerns and quality of life
|Breast Cancer Research and Treatment|1996|496
Neurocognitive Performance in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy and Tamoxifen
|Journal of Clinical and Experimental Neuropsychology|2004|400
Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy
|Breast Cancer Research and Treatment|2006|399